C12N 2501/608
Lin28
C12N2501/608 (Lin28) appears on 118 US grants and 222 published applications in this corpus.
Search patents in C12N- Granted patents
- 118
- Published applications
- 222
- Assignees
- 109
- Inventors
- 336
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 7 |
| 2011 | 0 | 12 |
| 2012 | 2 | 14 |
| 2013 | 4 | 15 |
| 2014 | 7 | 14 |
| 2015 | 8 | 10 |
| 2016 | 14 | 13 |
| 2017 | 10 | 20 |
| 2018 | 13 | 17 |
| 2019 | 11 | 15 |
| 2020 | 8 | 15 |
| 2021 | 5 | 14 |
| 2022 | 8 | 9 |
| 2023 | 8 | 14 |
| 2024 | 12 | 14 |
| 2025 | 5 | 11 |
| 2026 | 3 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Immune cells derived from induced pluripotent stem cell14 Jul 2026US 12,680,075 B2Children's Medical Center Corporation
- RNA preparations comprising purified modified RNA for reprogramming cells16 Jun 2026US 12,655,395 B2
- Methods and compositions for reprogramming cells14 Apr 2026US 12,600,968 B2The Regents of the University of Colorado, a body corporate
- Induced stem cells9 Dec 2025US 12,492,372 B2Monash University
- Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs16 Sep 2025US 12,415,989 B2Fate Therapeutics, Inc.
- Rna preparations comprising purified modified rna for reprogramming cells1 Oct 2026US 2026/0297538 A1The Trustees of the University of Pennsylvania
- System and method for capillary blood stem cell reprogramming using upper-arm blood collection devices for patient-specific disease modeling10 Sep 2026US 2026/0265698 A1TimepointDx
- Method for reprogramming human somatic cells into induced pluripotent stem cells14 May 2026US 2026/0132384 A1Exoneuglia Biotechnology (Suzhou) Co., Ltd.
- Methods and products for transfection30 Apr 2026US 2026/0117193 A1Factor Bioscience Inc.
- Induced stem cells19 Feb 2026US 2026/0049275 A1Monash University
Most cited
By later US patents
- Compositions and methods for reprogramming eukaryotic cells103US 8,808,982 B2Cellscript, LLC · 2014
- Methods for the production of iPS cells using non-viral approach45US 8,546,140 B2Cellular Dynamics International, Inc. · 2013
- OCT4 and SOX2 with SV40 T antigen produce pluripotent stem cells from primate somatic cells30US 8,268,620 B2Wisconsin Alumni Research Foundation · 2012
- Composition comprising recombinant nucleic acid encoding Sox2, Oct-4, Nanog and Lin2821US 8,183,038 B2Wisconsin Alumni Research Foundation · 2012
- Reprogramming somatic cells using retroviral vectors comprising Oct-4 and Sox2 genes21US 8,440,461 B2Wisconsin Alumni Research Foundation · 2013